Also known as: FUND INC
Rheumatology Research And Educational Fund Inc. is a private corporation based in CHICAGO, IL. The foundation received its IRS ruling in 2016. It holds total assets of $781K. Annual income is reported at $501K. TO SUPPORT ONGOING ACADEMIC RESEARCH STUDIES TO UNDERSTAND RHEUMATOLOGIC CONDITIONS BETTER AND INITIATE MORE EFFECTIVE TREATMENT FOR THEM. THE MOST SIGNIFICANT ACTIVITY IS GETTING MULTIPLE STUDIES PUBLISHED ON CONCOMITANT FIBROMYALGIA AND LUPUS BECAUSE FIBROMYALGIA IS HIDDEN, AND IF YOU DO A LUPUS DRUG STUDY YOU MAY FIND IT UNSUCCESSFUL WITHOUT UNDERSTANDING THAT SOME OF THESE PATIENTS ALSO HAVE INTRACTABLE PAIN AND FIBROMYALGIA. Contributions to this foundation are tax-deductible.
TO SUPPORT ONGOING ACADEMIC RESEARCH STUDIES TO UNDERSTAND RHEUMATOLOGIC CONDITIONS BETTER AND INITIATE MORE EFFECTIVE TREATMENT FOR THEM. THE MOST SIGNIFICANT ACTIVITY IS GETTING MULTIPLE STUDIES PUBLISHED ON CONCOMITANT FIBROMYALGIA AND LUPUS BECAUSE FIBROMYALGIA IS HIDDEN, AND IF YOU DO A LUPUS DRUG STUDY YOU MAY FIND IT UNSUCCESSFUL WITHOUT UNDERSTANDING THAT SOME OF THESE PATIENTS ALSO HAVE INTRACTABLE PAIN AND FIBROMYALGIA.
TO SUPPORT ONGOING ACADEMIC RESEARCH STUDIES TO UNDERSTAND RHEUMATOLOGIC CONDITIONS BETTER AND INITIATE MORE EFFECTIVE TREATMENT FOR THEM. THE MOST SIGNIFICANT ACTIVITY IS GETTING MULTIPLE STUDIES PUBLISHED ON CONCOMITANT FIBROMYALGIA AND LUPUS BECAUSE FIBROMYALGIA IS HIDDEN, AND IF YOU DO A LUPUS DRUG STUDY YOU MAY FIND IT UNSUCCESSFUL WITHOUT UNDERSTANDING THAT SOME OF THESE PATIENTS ALSO HAVE INTRACTABLE PAIN AND FIBROMYALGIA.
Rheumatology Research And Educational Fund Inc. typically selects its grantees rather than accepting unsolicited proposals.
Rheumatology Research And Educational Fund Inc. is headquartered in CHICAGO, IL.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Robert S Katz | DIRECTOR, PRESIDENT | $0 | $0 | $0 |
| Carlen J Katz | DIRECTOR | $0 | $0 | $0 |
| Alexandra Katz Small | DIRECTOR | $0 | $0 | $0 |
| Year | Return Type | |
|---|---|---|
| 2023 | 990PF | View |
© 2026 Granted AI